Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Biome Technologies division wins £0.54m contract

(Sharecast News) - Bioplastics and radiofrequency technology specialist Biome Technologies announced a new contract for its RF technologies division Stanelco on Friday. The AIM-traded firm said the contract, boasting revenue of £0.54m, would entails th provision of two radiofrequency welding systems to an unnamed international corporation operating within the medical supply sector.

It said the systems, designed with a modular machine platform that integrates automation and RF welding, would be constructed and tested at Biome's Marchwood, UK facility.

Following rigorous testing, they would be combined with additional production line equipment sourced from the end-customer's designated contractor.

Final assembly would also occur at a facility in the UK.

Expected to be completed within the 2024 financial year, the project's progression would be marked by stage payments aligned with predefined milestones throughout the contract.

"This important order results from the division's ongoing strategy of diversification beyond its traditional strength into new high-value medical market areas," said chief executive officer Paul Mines.

"The division continues to work on further potential opportunities and we remain confident in bringing another of these opportunities to a similar conclusion in the coming months."

At 0808 GMT, shares in Biome Technologies were up 10.71% at 116.25p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

UBS to book $900m provision over Greensill supply financing funds
(Sharecast News) - Swiss banking giant UBS announced on Monday that it expected to book a provision of about $900m related to Credit Suisse's funds, tied to the collapsed supply chain financing firm Greensill Capital.
Citi downgrades European equities to 'neutral'
(Sharecast News) - Citi downgraded its stance on European equities on Monday to 'neutral' from 'overweight' as it said near-term risks have increased, with markets narrowing and political uncertainty taking centre stage.
Hutchmed publishes positive sovleplenib trial results
(Sharecast News) - Hutchmed China announced the publication of positive results from its phase three 'ESLIM-01' trial of sovleplenib in the Lancet Haematology.
Somero trading in line with expectations
(Sharecast News) - Somero Enterprises said in an update on Monday that trading for the first five months of 2024 was consistent with expectations.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.